Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

MEI Pharma Company Profile (NASDAQ:MEIP)

Consensus Ratings for MEI Pharma (NASDAQ:MEIP) (?)
Ratings Breakdown: 5 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.40 (122.87% upside)

Analysts' Ratings History for MEI Pharma (NASDAQ:MEIP)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/8/2014Cantor FitzgeraldInitiated CoverageBuy$14.00ViewTweet This Rating  Share This Rating on StockTwits
7/8/2014Brean CapitalInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Brean CapitalInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
12/5/2013WedbushInitiated CoverageOutperform$12.00ViewTweet This Rating  Share This Rating on StockTwits
10/22/2013Stifel NicolausBoost Price TargetBuy$11.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
10/21/2013Roth CapitalBoost Price TargetBuy$16.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
5/24/2013Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
4/15/2013Stifel NicolausInitiated CoverageBuy$11.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/23/2012 forward)
Discuss MEI Pharma